Targeted inhibition of complement activation prevents features of preeclampsia in mice (Q46329692)

21 December 2017

title

Targeted inhibition of complement activation prevents features of preeclampsia in mice (English)

1 reference

21 December 2017

0 references

0 references

Xiaoping Qing

1

1 reference

21 December 2017

Stephen Tomlinson

4

1 reference

21 December 2017

Patricia B. Redecha

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20944547

1 August 2024

Melissa A. Burmeister

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20944547

1 August 2024

Vivette D. D'Agati

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20944547

1 August 2024

Robin L. Davisson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20944547

1 August 2024

Jane E. Salmon

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20944547

1 August 2024

language of work or name

English

0 references

publication date

13 October 2010

1 reference

21 December 2017

full work available at URL

http://www.kidney-international.org/article/S0085253815548047/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20944547

https://api.elsevier.com/content/article/PII:S0085253815548047?httpAccept=text/xml

1 August 2024

1 reference

https://api.crossref.org/works/10.1038/KI.2010.393

https://api.elsevier.com/content/article/PII:S0085253815548047?httpAccept=text/plain

1 August 2024

1 reference

https://api.crossref.org/works/10.1038/KI.2010.393

1 August 2024

1 reference

21 December 2017

volume

79

1 reference

21 December 2017

issue

3

1 reference

21 December 2017

page(s)

331-339

1 reference

21 December 2017

Preeclampsia--a pressing problem: an executive summary of a National Institute of Child Health and Human Development workshop

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Preeclampsia: recent insights

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Pathogenesis of preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Circulating angiogenic factors and the risk of preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Complement activation fragment Bb in early pregnancy and spontaneous preterm birth

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

The complement system in the pathophysiology of pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

The C5b-9 membrane attack complex of complement activation localizes to villous trophoblast injury in vivo and modulates human trophoblast function in vitro

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Advances in understanding of pathogenesis of aHUS and HELLP.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Complement receptor 2-mediated targeting of complement inhibitors to sites of complement activation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Targeted complement inhibition by C3d recognition ameliorates tissue injury without apparent increase in susceptibility to infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Renal morphology in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Renal pathology in pre-eclampsia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

The renal lesion of preeclampsia revisited

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Uterine natural killer cells: insights into their cellular and molecular biology from mouse modelling

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Adrenomedullin gene expression differences in mice do not affect blood pressure but modulate hypertension-induced pathology in males

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Eclampsia in the United Kingdom.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Complement-dependent P-selectin expression and injury following ischemic stroke

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Distinct receptor and regulatory properties of recombinant mouse complement receptor 1 (CR1) and Crry, the two genetic homologues of human CR1

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Placental isoprostane is significantly increased in preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Recent Insights into the pathogenesis of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Latest advances in understanding preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Preeclampsia and angiogenic imbalance

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Recombinant vascular endothelial growth factor 121 attenuates hypertension and improves kidney damage in a rat model of preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+CD25+ T regulatory cells prevents fetal rejection in a murine abortion model

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.2010.393

1 reference

7 January 2021

Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

A critical role for murine complement regulator crry in fetomaternal tolerance

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Complement C3 activation is required for antiphospholipid antibody-induced fetal loss

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

A critical role for the programmed death ligand 1 in fetomaternal tolerance

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Oxidative stress renders retinal pigment epithelial cells susceptible to complement-mediated injury.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

VEGF inhibition and renal thrombotic microangiopathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Circulating angiogenic factors in gestational proteinuria without hypertension

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Discovery of a spontaneous genetic mouse model of preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Chronic tempol prevents hypertension, proteinuria, and poor feto-placental outcomes in BPH/5 mouse model of preeclampsia

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.393

7 January 2021

Complement, neutrophil, and macrophage activation in women with severe preeclampsia and the syndrome of hemolysis, elevated liver enzymes, and low platelet count

https://api.crossref.org/works/10.1038/KI.2010.393

55

1 reference

1 August 2024

Identifiers

DOI

10.1038/KI.2010.393

1 reference

21 December 2017

1 reference

21 December 2017